Outcome and impact of post-remission strategy after MIDAM regimen in patients with relapsing or refractory acute myeloid leukemia.

Salem Mohammad BahashwanCécile Moluçon-ChabrotEric HermetAurélie RavinetAurore DougeLauren VeroneseAndrei TchirkovRichard LemalMarc G BergerRichard Veyrat-MassonOlivier TournilhacJacques-Olivier BayRomain Guièze

Published in: American journal of hematology (2018)

Keyphrases

acute myeloid leukemia
disease activity
multiple sclerosis
rheumatoid arthritis
systemic lupus erythematosus
allogeneic hematopoietic stem cell transplantation
ulcerative colitis